179 related articles for article (PubMed ID: 6414386)
21. Effects of puberty on bone age maturation in a girl after medulloblastoma therapy.
Marx M; Schoof E; Grabenbauer GG; Beck JD; Doerr HG
J Pediatr Adolesc Gynecol; 1999 May; 12(2):62-6. PubMed ID: 10326189
[TBL] [Abstract][Full Text] [Related]
22. Impact of craniospinal dose, boost volume, and neurologic complications on intellectual outcome in patients with medulloblastoma.
Moxon-Emre I; Bouffet E; Taylor MD; Laperriere N; Scantlebury N; Law N; Spiegler BJ; Malkin D; Janzen L; Mabbott D
J Clin Oncol; 2014 Jun; 32(17):1760-8. PubMed ID: 24516024
[TBL] [Abstract][Full Text] [Related]
23. Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial.
Gajjar A; Chintagumpala M; Ashley D; Kellie S; Kun LE; Merchant TE; Woo S; Wheeler G; Ahern V; Krasin MJ; Fouladi M; Broniscer A; Krance R; Hale GA; Stewart CF; Dauser R; Sanford RA; Fuller C; Lau C; Boyett JM; Wallace D; Gilbertson RJ
Lancet Oncol; 2006 Oct; 7(10):813-20. PubMed ID: 17012043
[TBL] [Abstract][Full Text] [Related]
24. Spontaneous nocturnal growth hormone secretion in children after medulloblastoma therapy.
Marx M; Beck JD; Grabenbauer GG; Dörr HG
Med Pediatr Oncol; 2001 Apr; 36(4):494-6. PubMed ID: 11260575
[No Abstract] [Full Text] [Related]
25. Treatment of pediatric average-risk medulloblastoma using craniospinal irradiation less than 2500 cGy and chemotherapy: single center experience in Korea.
Yoon JH; Park KD; Kang HJ; Kim H; Lee JW; Kim SK; Wang KC; Park SH; Kim IH; Shin HY
World J Pediatr; 2017 Aug; 13(4):367-373. PubMed ID: 28550392
[TBL] [Abstract][Full Text] [Related]
26. Medulloblastoma in very young children: outcome of definitive craniospinal irradiation following incomplete response to chemotherapy.
Gajjar A; Mulhern RK; Heideman RL; Sanford RA; Douglass EC; Kovnar EH; Langston JA; Jenkins JJ; Kun LE
J Clin Oncol; 1994 Jun; 12(6):1212-6. PubMed ID: 8201384
[TBL] [Abstract][Full Text] [Related]
27. Hyperprolactinemia and hypothyroidism following cytotoxic therapy for central nervous system malignancies.
Constine LS; Rubin P; Woolf PD; Doane K; Lush CM
J Clin Oncol; 1987 Nov; 5(11):1841-51. PubMed ID: 3681371
[TBL] [Abstract][Full Text] [Related]
28. Childhood medulloblastoma: progress and future challenges.
Packer RJ
Brain Dev; 1999 Mar; 21(2):75-81. PubMed ID: 10206522
[TBL] [Abstract][Full Text] [Related]
29. Spinal Growth Patterns After Craniospinal Irradiation in Children With Medulloblastoma.
Johnson SB; Hung J; Kapadia N; Oh KS; Kim M; Hamstra DA
Pract Radiat Oncol; 2019 Jan; 9(1):e22-e28. PubMed ID: 30036592
[TBL] [Abstract][Full Text] [Related]
30. Endocrinological late effects of oncologic treatment on survivors of medulloblastoma.
Hidalgo Santos AD; de Mingo Alemany MDC; Moreno Macián F; León Cariñena S; Collado Ballesteros E; Cañete Nieto A
Rev Chil Pediatr; 2019 Dec; 90(6):598-605. PubMed ID: 32186582
[TBL] [Abstract][Full Text] [Related]
31. [Combined radio-immuno-chemotherapy for medulloblastoma].
Suzuki M; Watanabe T; Katakura R; Suzuki J; Mori T; Wada T
No Shinkei Geka; 1983 Dec; 11(12):1271-6. PubMed ID: 6669213
[TBL] [Abstract][Full Text] [Related]
32. Survival and neurodevelopmental outcome of young children with medulloblastoma at St Jude Children's Research Hospital.
Walter AW; Mulhern RK; Gajjar A; Heideman RL; Reardon D; Sanford RA; Xiong X; Kun LE
J Clin Oncol; 1999 Dec; 17(12):3720-8. PubMed ID: 10577843
[TBL] [Abstract][Full Text] [Related]
33. Optimal therapy in medulloblastoma.
Bongartz EB; Bamberg M; Nau HE; Schmitt G; Bayindir C
Acta Neurochir (Wien); 1979; 50(1-2):117-25. PubMed ID: 517183
[TBL] [Abstract][Full Text] [Related]
34. Quality of survival and growth in children and young adults in the PNET4 European controlled trial of hyperfractionated versus conventional radiation therapy for standard-risk medulloblastoma.
Kennedy C; Bull K; Chevignard M; Culliford D; Dörr HG; Doz F; Kortmann RD; Lannering B; Massimino M; Navajas Gutiérrez A; Rutkowski S; Spoudeas HA; Calaminus G;
Int J Radiat Oncol Biol Phys; 2014 Feb; 88(2):292-300. PubMed ID: 24239386
[TBL] [Abstract][Full Text] [Related]
35. Medulloblastoma: new insights into biology and treatment.
Pizer B; Clifford S
Arch Dis Child Educ Pract Ed; 2008 Oct; 93(5):137-44. PubMed ID: 18809691
[No Abstract] [Full Text] [Related]
36. Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapy.
Packer RJ; Sutton LN; Elterman R; Lange B; Goldwein J; Nicholson HS; Mulne L; Boyett J; D'Angio G; Wechsler-Jentzsch K
J Neurosurg; 1994 Nov; 81(5):690-8. PubMed ID: 7931615
[TBL] [Abstract][Full Text] [Related]
37. The evaluation of function and the ultrasonographic picture of thyroid in children treated for medulloblastoma.
Sobol G; Musioł K; Kalina M; Kalina-Faska B; Mizia-Malarz A; Ficek K; Mandera M; Woś H; Małecka-Tendera E
Childs Nerv Syst; 2012 Mar; 28(3):399-404. PubMed ID: 22080382
[TBL] [Abstract][Full Text] [Related]
38. Medulloblastomas: a review of 11 cases.
Gómez Perún J; Carcavilla L; Eiras J; Alberdi J; Pisón J; Arana T
Childs Nerv Syst; 1987; 3(6):361-3. PubMed ID: 3329959
[TBL] [Abstract][Full Text] [Related]
39. Local control after craniospinal irradiation, intensity-modulated radiotherapy boost, and chemotherapy in childhood medulloblastoma.
Paulino AC; Mazloom A; Teh BS; South M; Okcu MF; Su J; Butler EB; Chintagumpala M
Cancer; 2011 Feb; 117(3):635-41. PubMed ID: 20845476
[TBL] [Abstract][Full Text] [Related]
40. Local control in non-metastatic medulloblastoma.
Christopherson KM; Bradley JA; Rotondo RL; Pincus DW; Fort JA; Morris CG; Mendenhall NP; Marcus RB; Indelicato DJ
Acta Oncol; 2014 Sep; 53(9):1151-7. PubMed ID: 24991891
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
